Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) SHH
8.15
-0.13(-1.57%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
8.15
-0.13(-1.57%)
Currency In CNY
Address
1/16 Nanjing Jiangbei New
Nanjing, 210061
China
Phone
86 25 8699 0700
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1451
First IPO Date
July 19, 2017
| Name | Title | Pay | Year Born |
| Tang Yongqun | GM & Chairman | 0 | 1976 |
| Xiaojie Qian | Financial Manager | 0 | 1980 |
| Wu Guiping | Deputy General Manager | 0 | 1963 |
| Xiaomei Gu | Accounting Supervisor | 0 | N/A |
| Huang Xiwei | Deputy GM, Secretary & Director | 0 | 1970 |
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd manufactures and sells heparin sodium and low molecular weight heparin products for pharmaceutical companies in the People's Republic of China. It offers enoxaparin sodium, dalteparin sodium, and naqu heparin calcium injections. The company also exports its products primarily to the European and American countries. The company was founded in 2000 and is based in Nanjing, the People's Republic of China.